Commitment to achieving Net Zero
Huma Therapeutics Limited is committed to achieving Net Zero emissions by 2050. Our Carbon Reduction Plan delineates our current emissions data, future targets, and strategic actions to realise our environmental goals. This document provides an overview of our baseline emissions, reduction targets, and the methodologies adhered to in our reporting process.
Baseline Emissions
Our baseline emissions have been calculated via an independent third party, reflecting our most up-to-date emissions data, which serve as our baseline emissions data. The calculations conform to the GHG Reporting Protocol corporate standard and the UK Government's Department for Business, Energy & Industrial Strategy (BEIS) team’s conversion factors. Our emissions calculations are based on the Financial Control emission boundary.
Baseline Year: 2022
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Current Emissions
Current reporting year set as baseline year
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Emissions Reduction Targets
Carbon Reduction Projects
Declaration and Sign Off
This Carbon reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.
This Carbon Reduction Plan has been reviewed and signed off by Mark Gilder.
© 2026 iPLATO. All rights reserved
Commitment to achieving Net Zero
Huma Therapeutics Limited is committed to achieving Net Zero emissions by 2050. Our Carbon Reduction Plan delineates our current emissions data, future targets, and strategic actions to realise our environmental goals. This document provides an overview of our baseline emissions, reduction targets, and the methodologies adhered to in our reporting process.
Baseline Emissions
Our baseline emissions have been calculated via an independent third party, reflecting our most up-to-date emissions data, which serve as our baseline emissions data. The calculations conform to the GHG Reporting Protocol corporate standard and the UK Government's Department for Business, Energy & Industrial Strategy (BEIS) team’s conversion factors. Our emissions calculations are based on the Financial Control emission boundary.
Baseline Year: 2022
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Current Emissions
Current reporting year set as baseline year
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Emissions Reduction Targets
Carbon Reduction Projects
Declaration and Sign Off
This Carbon reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.
This Carbon Reduction Plan has been reviewed and signed off by Mark Gilder.
© 2026 iPLATO. All rights reserved

Carbon Reduction Plan
Carbon Reduction Plan
Huma Therapeutics Limited
21 June 2024
Commitment to achieving Net Zero
Huma Therapeutics Limited is committed to achieving Net Zero emissions by 2050. Our Carbon Reduction Plan delineates our current emissions data, future targets, and strategic actions to realise our environmental goals. This document provides an overview of our baseline emissions, reduction targets, and the methodologies adhered to in our reporting process.
Baseline Emissions
Our baseline emissions have been calculated via an independent third party, reflecting our most up-to-date emissions data, which serve as our baseline emissions data. The calculations conform to the GHG Reporting Protocol corporate standard and the UK Government's Department for Business, Energy & Industrial Strategy (BEIS) team’s conversion factors. Our emissions calculations are based on the Financial Control emission boundary.
Baseline Year: 2022
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Current Emissions
Current reporting year set as baseline year
Emissions
Total (tCO2e)
GHG protocol breakdown by scope
Scope 1
0**
Direct Emissions from fuel combustion in own buildings and vehicles
Scope 2
5*
Emissions from electricity and heating use in control of the company (Market-based)
Scope 3
1013
Emissions from the corporate value chain
Total Emissions
1018
* Our location-based scope 2 emissions for the baseline year amounted to 39.31 tCO2e.
** NA / Too small to warrant monitoring
Emissions Reduction Targets
Carbon Reduction Projects
Declaration and Sign Off
This Carbon reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.
This Carbon Reduction Plan has been reviewed and signed off by Mark Gilder.
© 2026 iPLATO. All rights reserved